Anti-Human IGF1 & IGF2 Recombinant Antibody(Dusigitumab)
-
产品编号
YR1296
-
别名
科研级 Dusigitumab ( 度司妥单抗 ), Anti-IGF1 & IGF2 Recombinant Antibody, Research Grade Dusigitumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Dusigitumab ( 度司妥单抗 ), Anti-IGF1 & IGF2 Recombinant Antibody, Research Grade Dusigitumab |
Catalog Number | YR1296 |
Molecular Name | Dusigitumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2 |
Formulation | PBS, pH7.5 |
Background | Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix. |
CAS Number | 1204390-13-5 |
Application | Neut, ELISA, IF, IP, FuncS, FCM, IHC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IGF1 & IGF2[Homo sapiens] |